Literature DB >> 32666839

Stereological and histopathological evaluation of doxorubicin-induced toxicity in female rats' ovary and uterus and palliative effects of quercetin and vitamin E.

M Samare-Najaf1, F Zal1,2, S Safari3, F Koohpeyma4, N Jamali1.   

Abstract

Doxorubicin (DOX) is a widely used chemotherapeutic agent with demonstrated reproductive toxicity. This study sought to determine the DOX-induced toxicity in the ovary and uterus and the preventive effects of quercetin (QCT) and vitamin E (Vit.E). Female rats were divided into six groups as follows: control, QCT (20 mg/kg), Vit.E (200 mg/kg), DOX (accumulative 15 mg/kg), DOX/QCT, and DOX/Vit.E. After 3 weeks, the toxicity of DOX in ovarian and uterine tissues and the potential palliative effects of QCT and Vit.E were evaluated by histopathological-stereological methods. The findings indicate a dramatic decline in the number of ovarian follicles (p < 0.001), ovarian and its associated structures volume, the volume of the uterus, its layers, and related structures (p < 0.05). Coadministration of QCT and Vit.E with DOX-treated rats demonstrated an alleviative effect on most of the studied parameters. Nevertheless, few adverse effects were recognized concerning these antioxidants administration (p < 0.05). In conclusion, the findings of this study support the protective role of these dietary supplements in the prevention of DOX-induced toxicity in uterine and ovarian tissues.

Entities:  

Keywords:  Chemotherapy; cancer; doxorubicin; infertility; toxicity

Mesh:

Substances:

Year:  2020        PMID: 32666839     DOI: 10.1177/0960327120937329

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  2 in total

1.  Effects of Vitamin E on Doxorubicin Cytotoxicity in Human Breast Cancer Cells in Vitro.

Authors:  Mohadeseh Ahmadi; Akbar Hedayatizadeh-Omran; Reza Alizadeh-Navaei; Majid Saeedi; Ehsan Zaboli; Omolbanin Amjadi; Hamidreza Kelidari; Zahra Besharat
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

Review 2.  Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression-3PM pathways.

Authors:  Peter Kubatka; Alena Mazurakova; Marek Samec; Lenka Koklesova; Kevin Zhai; Raghad Al-Ishaq; Karol Kajo; Kamil Biringer; Desanka Vybohova; Aranka Brockmueller; Martin Pec; Mehdi Shakibaei; Frank A Giordano; Dietrich Büsselberg; Olga Golubnitschaja
Journal:  EPMA J       Date:  2021-10-06       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.